✦ LIBER ✦

The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer

✍ Scribed by Khalil, Mohamed A.; Qiao, Wei; Carlson, Peter; George, Binsah; Javle, Milind; Overman, Michael; Varadhachary, Gauri; Wolff, Robert A.; Abbruzzese, James L.; Fogelman, David R.

Book ID: 125358919
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 246 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-013-9967-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Folinic acid dose and addition of levami

Folinic acid dose and addition of levamisole does not seem to improve survival or recurrence rates in people treated with adjuvant fluorouracil and folinic acid for colorectal cancer

✍ Philippe Rougier 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Recurrence rates and survival in patient

Recurrence rates and survival in patients with colorectal cancer do not appear to be improved by adding levamisole to adjuvant chemotherapy or by increasing the dosage of calcium levofolinate

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB